$SGMO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in SANGAMO THERAPEUTICS, INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in SANGAMO THERAPEUTICS, INC. Get notifications about new insider transactions in SANGAMO THERAPEUTICS, INC for free.
Page: < prev 1 ... 4 5 6 7 8 9 10 11 12 ... 16 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.45 | 2,000 | 6,900 | 194,000 | |
| Oct 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.61 | 10,000 | 36,100 | 10,000 | |
| Oct 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 10.39 | 3,000 | 31,156 | 86,798 | 89.8 K to 86.8 K (-3.34 %) |
| Oct 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 5.19 | 3,000 | 15,570 | 89,798 | 86.8 K to 89.8 K (+3.46 %) |
| Oct 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 10.39 | 12,000 | 124,624 | 86,798 | 98.8 K to 86.8 K (-12.15 %) |
| Oct 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.45 | 2,000 | 6,900 | 98,798 | 96.8 K to 98.8 K (+2.07 %) |
| Oct 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.61 | 10,000 | 36,100 | 96,798 | 86.8 K to 96.8 K (+11.52 %) |
| Oct 23 2013 | SGMO | SANGAMO BIOSCIENCE ... | Cleveland Paul B | Director | Option Exercise | M | 4.54 | 10,000 | 45,400 | 0 | |
| Oct 23 2013 | SGMO | SANGAMO BIOSCIENCE ... | Cleveland Paul B | Director | Sell | S | 10.93 | 10,000 | 109,336 | 0 | 10 K to 0 (-100.00 %) |
| Oct 23 2013 | SGMO | SANGAMO BIOSCIENCE ... | Cleveland Paul B | Director | Buy | M | 4.54 | 10,000 | 45,400 | 10,000 | 0 to 10 K |
| Oct 17 2013 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Gift | G | 0.00 | 13,500 | 0 | 1,567,452 | 1.6 M to 1.6 M (-0.85 %) |
| Oct 17 2013 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Sell | S | 11.32 | 25,000 | 283,083 | 1,580,952 | 1.6 M to 1.6 M (-1.56 %) |
| Oct 15 2013 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Option Exercise | M | 3.45 | 10,000 | 34,500 | 232,000 | |
| Oct 15 2013 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Sell | S | 11.28 | 10,000 | 112,763 | 209,219 | 219.2 K to 209.2 K (-4.56 %) |
| Oct 15 2013 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Buy | M | 3.45 | 10,000 | 34,500 | 219,219 | 209.2 K to 219.2 K (+4.78 %) |
| Oct 04 2013 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Option Exercise | M | 3.45 | 8,000 | 27,600 | 94,709 | |
| Oct 04 2013 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Option Exercise | M | 5.19 | 7,000 | 36,330 | 0 | |
| Oct 04 2013 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Sell | S | 10.54 | 15,000 | 158,081 | 90,000 | 105 K to 90 K (-14.29 %) |
| Oct 04 2013 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Buy | M | 3.45 | 8,000 | 27,600 | 105,000 | 97 K to 105 K (+8.25 %) |
| Oct 04 2013 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Buy | M | 5.19 | 7,000 | 36,330 | 97,000 | 90 K to 97 K (+7.78 %) |
| Jul 19 2013 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Option Exercise | M | 3.45 | 10,000 | 34,500 | 262,000 | |
| Jul 19 2013 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Sell | S | 10.00 | 10,000 | 100,000 | 209,219 | 219.2 K to 209.2 K (-4.56 %) |
| Jul 19 2013 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Buy | M | 3.45 | 10,000 | 34,500 | 219,219 | 209.2 K to 219.2 K (+4.78 %) |
| Sep 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 5.19 | 3,000 | 15,570 | 18,000 | |
| Sep 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.45 | 2,000 | 6,900 | 196,000 | |
| Sep 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.61 | 10,000 | 36,100 | 20,000 | |
| Sep 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 10.56 | 3,000 | 31,684 | 84,798 | 87.8 K to 84.8 K (-3.42 %) |
| Sep 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 5.19 | 3,000 | 15,570 | 87,798 | 84.8 K to 87.8 K (+3.54 %) |
| Sep 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 10.57 | 12,000 | 126,890 | 84,798 | 96.8 K to 84.8 K (-12.40 %) |
| Sep 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.45 | 2,000 | 6,900 | 96,798 | 94.8 K to 96.8 K (+2.11 %) |
| Sep 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.61 | 10,000 | 36,100 | 94,798 | 84.8 K to 94.8 K (+11.79 %) |
| Sep 18 2013 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Sell | S | 11.29 | 25,000 | 282,128 | 1,605,952 | 1.6 M to 1.6 M (-1.53 %) |
| Sep 12 2013 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Option Exercise | M | 3.45 | 10,000 | 34,500 | 242,000 | |
| Sep 12 2013 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Sell | S | 10.86 | 10,000 | 108,593 | 209,219 | 219.2 K to 209.2 K (-4.56 %) |
| Sep 12 2013 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Buy | M | 3.45 | 10,000 | 34,500 | 219,219 | 209.2 K to 219.2 K (+4.78 %) |
| Sep 05 2013 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Option Exercise | M | 3.45 | 8,000 | 27,600 | 102,709 | |
| Sep 05 2013 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Option Exercise | M | 5.19 | 7,000 | 36,330 | 7,000 | |
| Sep 05 2013 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Sell | S | 10.33 | 15,000 | 154,982 | 90,000 | 105 K to 90 K (-14.29 %) |
| Sep 05 2013 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Buy | M | 3.45 | 8,000 | 27,600 | 105,000 | 97 K to 105 K (+8.25 %) |
| Sep 05 2013 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Buy | M | 5.19 | 7,000 | 36,330 | 97,000 | 90 K to 97 K (+7.78 %) |
| Sep 05 2013 | SGMO | SANGAMO BIOSCIENCE ... | Cleveland Paul B | Director | Option Exercise | M | 2.04 | 7,278 | 14,847 | 0 | |
| Sep 05 2013 | SGMO | SANGAMO BIOSCIENCE ... | Cleveland Paul B | Director | Sell | S | 10.30 | 7,278 | 74,978 | 0 | 7.3 K to 0 (-100.00 %) |
| Sep 05 2013 | SGMO | SANGAMO BIOSCIENCE ... | Cleveland Paul B | Director | Buy | M | 2.04 | 7,278 | 14,847 | 7,278 | 0 to 7.3 K |
| Aug 28 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 5.19 | 2,000 | 10,380 | 21,000 | |
| Aug 28 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.45 | 1,000 | 3,450 | 198,000 | |
| Aug 28 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.61 | 10,000 | 36,100 | 30,000 | |
| Aug 28 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 10.04 | 2,000 | 20,077 | 84,798 | 86.8 K to 84.8 K (-2.30 %) |
| Aug 28 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 10.04 | 2,000 | 20,077 | 86,798 | 88.8 K to 86.8 K (-2.25 %) |
| Aug 28 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 5.19 | 2,000 | 10,380 | 88,798 | 86.8 K to 88.8 K (+2.30 %) |
| Aug 28 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 10.04 | 11,000 | 110,453 | 86,798 | 97.8 K to 86.8 K (-11.25 %) |
| Aug 28 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.45 | 1,000 | 3,450 | 97,798 | 96.8 K to 97.8 K (+1.03 %) |
| Aug 28 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.61 | 10,000 | 36,100 | 96,798 | 86.8 K to 96.8 K (+11.52 %) |
| Aug 16 2013 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Sell | S | 10.12 | 25,000 | 252,880 | 1,630,952 | 1.7 M to 1.6 M (-1.51 %) |
| Aug 15 2013 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Option Exercise | M | 3.45 | 10,000 | 34,500 | 252,000 | |
| Aug 15 2013 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Sell | S | 10.00 | 10,000 | 100,000 | 209,219 | 219.2 K to 209.2 K (-4.56 %) |
| Aug 15 2013 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Buy | M | 3.45 | 10,000 | 34,500 | 219,219 | 209.2 K to 219.2 K (+4.78 %) |
| Aug 05 2013 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Option Exercise | M | 3.45 | 8,000 | 27,600 | 110,709 | |
| Aug 05 2013 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Option Exercise | M | 5.19 | 7,000 | 36,330 | 14,000 | |
| Aug 05 2013 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Sell | S | 9.89 | 15,000 | 148,322 | 90,000 | 105 K to 90 K (-14.29 %) |
| Aug 05 2013 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Buy | M | 3.45 | 8,000 | 27,600 | 105,000 | 97 K to 105 K (+8.25 %) |
| Aug 05 2013 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Buy | M | 5.19 | 7,000 | 36,330 | 97,000 | 90 K to 97 K (+7.78 %) |
| Jul 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 5.19 | 2,000 | 10,380 | 23,000 | |
| Jul 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.45 | 1,000 | 3,450 | 199,000 | |
| Jul 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.61 | 10,000 | 36,100 | 40,000 | |
| Jul 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 10.12 | 2,000 | 20,242 | 86,798 | 88.8 K to 86.8 K (-2.25 %) |
| Jul 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 10.12 | 2,000 | 20,239 | 88,798 | 90.8 K to 88.8 K (-2.20 %) |
| Jul 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 5.19 | 2,000 | 10,380 | 90,798 | 88.8 K to 90.8 K (+2.25 %) |
| Jul 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 10.08 | 11,000 | 110,827 | 88,798 | 99.8 K to 88.8 K (-11.02 %) |
| Jul 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.45 | 1,000 | 3,450 | 99,798 | 98.8 K to 99.8 K (+1.01 %) |
| Jul 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.61 | 10,000 | 36,100 | 98,798 | 88.8 K to 98.8 K (+11.26 %) |
| Jul 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Option Exercise | M | 3.45 | 8,000 | 27,600 | 118,709 | |
| Jul 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Option Exercise | M | 5.19 | 4,000 | 20,760 | 21,000 | |
| Jul 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Option Exercise | M | 4.92 | 3,000 | 14,760 | 0 | |
| Jul 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Sell | S | 10.02 | 8,000 | 80,143 | 90,000 | 98 K to 90 K (-8.16 %) |
| Jul 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Buy | M | 3.45 | 8,000 | 27,600 | 98,000 | 90 K to 98 K (+8.89 %) |
| Jul 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Sell | S | 10.06 | 7,000 | 70,412 | 90,000 | 97 K to 90 K (-7.22 %) |
| Jul 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Buy | M | 5.19 | 4,000 | 20,760 | 97,000 | 93 K to 97 K (+4.30 %) |
| Jul 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Buy | M | 4.92 | 3,000 | 14,760 | 93,000 | 90 K to 93 K (+3.33 %) |
| Jul 19 2013 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Sell | S | 10.00 | 25,000 | 250,003 | 1,655,952 | 1.7 M to 1.7 M (-1.49 %) |
| Jul 17 2013 | SGMO | SANGAMO BIOSCIENCE ... | Cleveland Paul B | Director | Option Exercise | M | 2.04 | 8,000 | 16,320 | 7,278 | |
| Jul 17 2013 | SGMO | SANGAMO BIOSCIENCE ... | Cleveland Paul B | Director | Sell | S | 9.59 | 8,000 | 76,718 | 0 | 8 K to 0 (-100.00 %) |
| Jul 17 2013 | SGMO | SANGAMO BIOSCIENCE ... | Cleveland Paul B | Director | Buy | M | 2.04 | 8,000 | 16,320 | 8,000 | 0 to 8 K |
| Jun 14 2013 | SGMO | SANGAMO BIOSCIENCE ... | Mento Steven J | Director | Option Exercise | A | 7.77 | 10,000 | 77,700 | 10,000 | |
| Jun 14 2013 | SGMO | SANGAMO BIOSCIENCE ... | Ramasastry Saira | Director | Option Exercise | A | 7.77 | 10,000 | 77,700 | 10,000 | |
| Jun 14 2013 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Option Exercise | A | 7.77 | 10,000 | 77,700 | 10,000 | |
| Jun 14 2013 | SGMO | SANGAMO BIOSCIENCE ... | DILLY STEPHEN GEORGE | Director | Option Exercise | A | 7.77 | 10,000 | 77,700 | 10,000 | |
| Jun 14 2013 | SGMO | SANGAMO BIOSCIENCE ... | RINGO WILLIAM R | Director | Option Exercise | A | 7.77 | 10,000 | 77,700 | 10,000 | |
| Jun 14 2013 | SGMO | SANGAMO BIOSCIENCE ... | Cleveland Paul B | Director | Option Exercise | A | 7.77 | 10,000 | 77,700 | 10,000 | |
| Jun 05 2013 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Option Exercise | M | 3.45 | 3,000 | 10,350 | 126,709 | |
| Jun 05 2013 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Sell | S | 7.88 | 3,000 | 23,640 | 90,000 | 93 K to 90 K (-3.23 %) |
| Jun 05 2013 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Buy | M | 3.45 | 3,000 | 10,350 | 93,000 | 90 K to 93 K (+3.33 %) |
| May 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.61 | 15,000 | 54,150 | 50,000 | |
| May 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 8.32 | 15,000 | 124,818 | 88,798 | 103.8 K to 88.8 K (-14.45 %) |
| May 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.61 | 15,000 | 54,150 | 103,798 | 88.8 K to 103.8 K (+16.89 %) |
| May 09 2013 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Option Exercise | M | 2.45 | 10,000 | 24,500 | 0 | |
| May 09 2013 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Buy | M | 2.45 | 10,000 | 24,500 | 218,160 | 208.2 K to 218.2 K (+4.80 %) |
| May 03 2013 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Option Exercise | M | 3.45 | 6,000 | 20,700 | 129,709 | |
| May 03 2013 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Sell | S | 10.09 | 6,000 | 60,557 | 90,000 | 96 K to 90 K (-6.25 %) |
| May 03 2013 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Buy | M | 3.45 | 6,000 | 20,700 | 96,000 | 90 K to 96 K (+6.67 %) |
| Apr 29 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.61 | 15,000 | 54,150 | 65,000 | |
| Apr 29 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 10.72 | 15,000 | 160,746 | 88,798 | 103.8 K to 88.8 K (-14.45 %) |
| Apr 29 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.61 | 15,000 | 54,150 | 103,798 | 88.8 K to 103.8 K (+16.89 %) |
| Apr 19 2013 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Gift | G | 0.00 | 12,000 | 0 | 1,680,952 | 1.7 M to 1.7 M (-0.71 %) |
| Apr 19 2013 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Sell | S | 10.00 | 190 | 1,900 | 1,692,952 | 1.7 M to 1.7 M (-0.01 %) |
| Apr 19 2013 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Sell | S | 10.00 | 5,000 | 50,000 | 1,693,142 | 1.7 M to 1.7 M (-0.29 %) |
| Apr 12 2013 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Option Exercise | M | 3.45 | 10,000 | 34,500 | 272,000 | |
| Apr 12 2013 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Sell | S | 10.00 | 10,000 | 100,000 | 209,219 | 219.2 K to 209.2 K (-4.56 %) |
| Apr 12 2013 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Grant | A | 3.45 | 10,000 | 34,500 | 219,219 | 209.2 K to 219.2 K (+4.78 %) |
| Apr 03 2013 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Option Exercise | M | 3.45 | 6,000 | 20,700 | 135,709 | |
| Apr 03 2013 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Sell | S | 9.54 | 6,000 | 57,240 | 90,000 | 96 K to 90 K (-6.25 %) |
| Apr 03 2013 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Buy | M | 3.45 | 6,000 | 20,700 | 96,000 | 90 K to 96 K (+6.67 %) |
| Mar 28 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.61 | 9,200 | 33,212 | 80,000 | |
| Mar 28 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.61 | 5,800 | 20,938 | 0 | |
| Mar 28 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 9.18 | 15,000 | 137,724 | 88,798 | 103.8 K to 88.8 K (-14.45 %) |
| Mar 28 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.61 | 9,200 | 33,212 | 103,798 | 94.6 K to 103.8 K (+9.73 %) |
| Mar 28 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.61 | 5,800 | 20,938 | 94,598 | 88.8 K to 94.6 K (+6.53 %) |
| Mar 01 2013 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Option Exercise | M | 4.92 | 6,000 | 29,520 | 3,000 | |
| Mar 01 2013 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Sell | S | 10.00 | 6,000 | 60,005 | 90,000 | 96 K to 90 K (-6.25 %) |
| Mar 01 2013 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Buy | M | 4.92 | 6,000 | 29,520 | 96,000 | 90 K to 96 K (+6.67 %) |
| Mar 01 2013 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Option Exercise | M | 3.45 | 10,000 | 34,500 | 282,000 | |
| Mar 01 2013 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Sell | S | 10.00 | 10,000 | 100,000 | 209,219 | 219.2 K to 209.2 K (-4.56 %) |
| Mar 01 2013 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Buy | M | 3.45 | 10,000 | 34,500 | 219,219 | 209.2 K to 219.2 K (+4.78 %) |
| Mar 01 2013 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Sell | S | 10.00 | 25,000 | 250,000 | 1,698,142 | 1.7 M to 1.7 M (-1.45 %) |
| Feb 28 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.61 | 15,000 | 54,150 | 5,800 | |
| Feb 28 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 8.64 | 15,000 | 129,600 | 88,798 | 103.8 K to 88.8 K (-14.45 %) |
| Feb 28 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.61 | 15,000 | 54,150 | 103,798 | 88.8 K to 103.8 K (+16.89 %) |
| Feb 05 2013 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Option Exercise | M | 4.92 | 6,000 | 29,520 | 9,000 | |
| Feb 05 2013 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Sell | S | 9.53 | 6,000 | 57,195 | 90,000 | 96 K to 90 K (-6.25 %) |
| Feb 05 2013 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Buy | M | 4.92 | 6,000 | 29,520 | 96,000 | 90 K to 96 K (+6.67 %) |
| Jan 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.61 | 15,000 | 54,150 | 20,800 | |
| Jan 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 9.68 | 15,000 | 145,158 | 88,798 | 103.8 K to 88.8 K (-14.45 %) |
| Jan 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.61 | 15,000 | 54,150 | 103,798 | 88.8 K to 103.8 K (+16.89 %) |
| Jan 28 2013 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Option Exercise | M | 3.45 | 8,000 | 27,600 | 292,000 | |
| Jan 28 2013 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Sell | S | 10.00 | 10,000 | 100,000 | 209,219 | 219.2 K to 209.2 K (-4.56 %) |
| Jan 28 2013 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Grant | A | 3.45 | 8,000 | 27,600 | 219,219 | 211.2 K to 219.2 K (+3.79 %) |
| Jan 28 2013 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Sell | S | 10.00 | 300 | 3,000 | 1,723,142 | 1.7 M to 1.7 M (-0.02 %) |
| Jan 28 2013 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Sell | S | 10.00 | 8,300 | 83,008 | 1,723,442 | 1.7 M to 1.7 M (-0.48 %) |
| Jan 04 2013 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Option Exercise | M | 4.92 | 6,000 | 29,520 | 15,000 | |
| Jan 04 2013 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Sell | S | 6.05 | 6,000 | 36,300 | 90,000 | 96 K to 90 K (-6.25 %) |
| Jan 04 2013 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Buy | M | 4.92 | 6,000 | 29,520 | 96,000 | 90 K to 96 K (+6.67 %) |
| Dec 28 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.61 | 15,000 | 54,150 | 35,800 | |
| Dec 28 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 5.92 | 15,000 | 88,830 | 88,798 | 103.8 K to 88.8 K (-14.45 %) |
| Dec 28 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.61 | 15,000 | 54,150 | 103,798 | 88.8 K to 103.8 K (+16.89 %) |
| Dec 28 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 5.94 | 2,000 | 11,888 | 88,798 | 90.8 K to 88.8 K (-2.20 %) |
| Dec 10 2012 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Option Exercise | M | 4.92 | 12,000 | 59,040 | 21,000 | |
| Dec 10 2012 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Option Exercise | A | 5.41 | 80,000 | 432,800 | 80,000 | |
| Dec 10 2012 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Sell | S | 6.00 | 12,000 | 72,000 | 90,000 | 102 K to 90 K (-11.76 %) |
| Dec 10 2012 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Buy | S | 4.92 | 12,000 | 59,040 | 102,000 | 90 K to 102 K (+13.33 %) |
| Dec 10 2012 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Grant | A | 0.00 | 40,000 | 0 | 90,000 | 50 K to 90 K (+80.00 %) |
| Dec 10 2012 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Option Exercise | A | 5.41 | 250,000 | 1,352,500 | 250,000 |